Niaid apr 2016 rl
-
Upload
center-for-disease-dynamics-economics-policy -
Category
Documents
-
view
227 -
download
0
description
Transcript of Niaid apr 2016 rl
![Page 1: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/1.jpg)
The State of the World’s Antibiotics
Ramanan Laxminarayan 2016 John Ring LaMontagne Memorial Lecture
![Page 2: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/2.jpg)
I. Drugresistanceisrisingworldwideandthreatensgainsmadeinreducingtheburdenofinfec7ousdiseases
![Page 3: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/3.jpg)
![Page 4: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/4.jpg)
![Page 5: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/5.jpg)
![Page 6: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/6.jpg)
![Page 7: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/7.jpg)
![Page 8: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/8.jpg)
![Page 9: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/9.jpg)
Percentage of Staphylococcus aureus isolates that are methicillin resistant (MRSA) in selected countries, 1999–2014
Source: CDDEP 2015 Depending on the country, resistance to one or more of the following drugs may have been used to test for MRSA: Oxacillin, cefoxitin, flucloxacillin, cloxacillin, dicloxacillin, and methicillin. Intermediate-resistant isolates are included as resistant
![Page 10: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/10.jpg)
![Page 11: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/11.jpg)
![Page 12: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/12.jpg)
![Page 13: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/13.jpg)
CREratesinchildrengrewbetween2000and2012
Loganetal,EID,2015
![Page 14: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/14.jpg)
![Page 15: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/15.jpg)
15
Clonal spread of S. pneumoniae 23F
Tennessee
Cleveland
Mexico
Colombia
Brazil
Argen7naUruguay
Chile SouthAfrica
SingaporeMalaysia
ThailandPhilippines
HongKongTaiwan
SouthKoreaSpain
FranceBM42001978?
Finland
Slidecourtesy:KeithKlugman
![Page 16: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/16.jpg)
Numbers of unique β-lactamase enzymes identified since introduction of first β-lactam antibiotics
![Page 17: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/17.jpg)
Clostridium difficile rates and oral vancomycin prescriptions
Polgreen,Yang,Kuntz,Laxminarayan,ICHE2011
![Page 18: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/18.jpg)
Mortality outcomes are worse in neonates with resistant infections
KayangeM,KamugishaE,MwizamholyaDL,JeremiahS,MshanaSE.2010.Predictorsofposi7vebloodcultureanddeathsamongneonateswithsuspectedneonatalsepsisinater7aryhospital,Mwanza-Tanzania.BMCPediatrics10:39.
149
58
369
151
91
55
23
0
10
20
30
40
50
60
Culture GramReac7on ESBL MRSA
Death(%
)
Parameter
Posi7ve
Nega7ve
![Page 19: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/19.jpg)
LaxminarayanetalLancet,2015
![Page 20: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/20.jpg)
![Page 21: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/21.jpg)
Absolute risk reduction (ARR) of infection with antibiotic prophylaxis in common surgical procedures and blood cancer chemotherapy in the USA
Teillantetal,LancetInfectDis,2015
![Page 22: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/22.jpg)
Number of additional infections per year in the USA under a 30% decreased efficacy of antibiotic prophylaxis
Teillantetal,LancetInfectDis,2015
![Page 23: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/23.jpg)
II. Risingincomesandincreasingaccesstoan7bio7csaresavinglives(althoughlackofaccesss7llkillsmorepeoplethanan7bio7cresistance)butarenotagoodsubs7tuteforpublichealth
![Page 24: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/24.jpg)
Bacterial diseases are still major killers in developing countries because of lack of access to antibiotics
O’Brienetal,Lancet2009
![Page 25: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/25.jpg)
Pneumococcal pneumonia deaths avertable with improved antibiotic access
Laxminarayanetal,Lancet,2015
![Page 26: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/26.jpg)
What are we asking of antibiotics?
![Page 27: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/27.jpg)
Substitute for immunization, infection control and water/sanitation
South Asia
![Page 28: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/28.jpg)
Substitute for immunization, infection control and water/sanitation
Sub-Saharan Africa
![Page 29: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/29.jpg)
Population without access to improved sanitation, by MDG region 2012
Source: WHO/UNICEF 2014
![Page 30: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/30.jpg)
Kyaw MH et al. N Engl J Med 2006;354:1455-1463.
Vaccines can be effective Invasive disease caused by Pneumococci in children under two declined in the US post pneumo vaccination
![Page 31: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/31.jpg)
Kyaw MH et al. N Engl J Med 2006;354:1455-1463.
Invasive disease caused by non-susceptible Pneumococci, US
![Page 32: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/32.jpg)
LaxminarayanetalLancet,2015
![Page 33: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/33.jpg)
Antibiotic consumption is increasing in developing countries...
Source: Based on data obtained under license from IMS Health MIDAS ™ (January 2005-December 2010); IMS Health Incorporated. All Rights Reserved.
0
5000
10000
15000
20000
25000
BRAZIL, RETAIL INDIA, RETAIL VIETNAM, RETAIL NORWAY, RETAIL USA, RETAIL
Stan
dard
Uni
ts pe
r 100
0 po
pula
tion
Per capita total antibiotic use, retail sector, 2005-2010
2005
2006
2007
2008
2009
2010
![Page 34: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/34.jpg)
-50 – -30 -29 – -20 -19 – -10 -9 – 0 1 – 10 11 – 20 21 – 40 41 – 80 >80 No data
Percentage change in antibiotic consumption per capita 2000–2010*, by country
Source: Van Boeckel et al. 2015 (adapted; based on IMS MIDAS) *Data for Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama were available only as a group classified as Central America. Similarly, data for Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Gabon, Guinea, Mali, Republic of the Congo, Senegal, and Togo were grouped and classified as French West Africa. The data for these countries represent the estimates for the corresponding regional groupings they belong to. For countries that did not have data available for 2000, the values for the earliest years for which data were available after 2000 were used to calculate the percentage changes. These countries and initial years are Algeria (2002), Bangladesh (2007), Croatia (2005), Netherlands (2005), and Vietnam (2005).
![Page 35: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/35.jpg)
Total antibiotic consumption in selected countries, 2000 and 2010
Van Boeckel et al. 2014 (based on IMS MIDAS)
![Page 36: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/36.jpg)
Antibiotic use per capita by income in selected countries, 2010
Source: Van Boeckel et al. 2014 (based on IMS MIDAS) and World Bank 2015
![Page 37: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/37.jpg)
Carbapenem retail sales in selected countries, 2005–2010 (per 1,000 population)
Source: Laxminarayan et al. 2013 (based on IMS MIDAS) *An IMS grouping of Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Gabon, Guinea, Mali, Republic of the Congo, Senegal, and Togo
![Page 38: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/38.jpg)
Faropenem consumption has increased by 154% since it was approved for use in India in 2010
Gandraetal,ClinInfDis,2016
![Page 39: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/39.jpg)
Carbapenem consumption in the hospital sector in selected European countries, 1997–2013
ESAC-Net 2015
![Page 40: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/40.jpg)
Non-prescription use of antimicrobials is common
Morganetal,LancetID,2011
![Page 41: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/41.jpg)
![Page 42: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/42.jpg)
![Page 43: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/43.jpg)
Van Boeckel et al, Lancet Inf Dis, 2014
The flu season is a key driver of antibiotic consumption
![Page 44: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/44.jpg)
Influenza in the United States is nearly perfectly predicted by antibiotic sales data
PolgreenetalInfContHospEpi,2011
![Page 45: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/45.jpg)
Hospital use of carbapenems is rapidly growing
0
10
20
30
40
50
60
70
VIETNAM, HOSPITAL CHINA, HOSPITAL NORWAY, HOSPITAL USA, HOSPITAL
Stand
ard
Units
per
100
0 po
pula
tion
Per capita total carbapenem use, hospital sector, 2005-2010
2005
2006
2007
2008
2009
2010
Source: Based on data obtained under license from IMS Health MIDAS ™ (January 1999-December 2010); IMS Health Incorporated. All Rights Reserved.
![Page 46: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/46.jpg)
![Page 47: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/47.jpg)
Global availability of colistin
Wertheim et al, JGAR 2013
![Page 48: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/48.jpg)
![Page 49: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/49.jpg)
Make better use of existing antibiotics
ImageCourtesyofShu^erstock
![Page 50: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/50.jpg)
Find new antibiotics
ImageCourtesyofShu^erstock
![Page 51: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/51.jpg)
III. Driversofan7bio7cuserelatetoincen7vesandbehaviorofpa7ents,physicians,pharma,payersandhealthcareins7tu7ons.
![Page 52: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/52.jpg)
Incentives for Physicians
• Sa7sfyingpa7entexpecta7ons
![Page 53: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/53.jpg)
Dosh,JFamPr1999
![Page 54: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/54.jpg)
Decision fatigue increases inappropriate prescribing
Linderetal,JAMAIM,2014
Rela7vetothefirsthourofasession,theadjustedoddsra7osofan7bio7cprescribinginthefourthhourwas1.26(95%CI,1.13–1.41)
![Page 55: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/55.jpg)
Health insurance increases prescribing
![Page 56: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/56.jpg)
What happens when antibiotics are provided free?
Overallincreaseinan7bio7cprescrip7onsaswellassubs7tu7onstocoveredan7bio7csfromnot-coveredan7bio7cs.
LiandLaxminarayan,HealthEconomics,2013
![Page 57: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/57.jpg)
What happens when antibiotics are provided free?
Overallincreaseinan7bio7cprescrip7onsaswellassubs7tu7onstocoveredan7bio7csfromnot-coveredan7bio7cs.
LiandLaxminarayan,HealthEconomics,2013
![Page 58: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/58.jpg)
Hospital Incentives
• An7bio7csareasubs7tuteforinfec7oncontrol
• Infec7oncontrolisodennotcompensated
![Page 59: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/59.jpg)
Comparedwithabsenceofcomplica7ons,complica7onswereassociatedwitha$39017highercontribu7onmarginperpa7entwithprivateinsurance($55953vs$16936)anda$1749highercontribu7onmarginperpa7entwithMedicare($3629vs$1880).
![Page 60: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/60.jpg)
10.8%
89.2%
0
200
400
600
800
1000
1200
No Yes
Num
berofPa7
ents
DocumentedDiagnosisforStar7ngIndexAn7bio7c
Braykovetal,LancetInfDis,2015
![Page 61: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/61.jpg)
30.1%
69.9%
0
100
200
300
400
500
600
No Yes
Num
berofPa7
ents(N
=730
)PresenceofFeverandHighWBCamongPa7entswith
EmpiricAn7bio7cTherapy
Respiratory(43%)
Urinarytract(18%)
Sod7ssue(18%)
Gastro-Intes7nal(8%)
Bloodstream(8%)
Other(6%)
BreakdownofInfec7onSitefor"No"Pa7ents
Braykovetal,LancetInfDis,2015
![Page 62: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/62.jpg)
Jus7fica7ons
73.4%
51.7%
11.1%
48.3%
15.5%
0
100
200
300
400
500
600
700
OneAn7bio7c TwoorMoreAn7bio7cs
Num
berofPa7
ents
Pa7entsReceivingAn7bio7csonIndexDay
ForDifferentIndica7ons
NoApparentReason
ToIncreaseSpectrumofCoverageforSingleIndica7on
Braykovetal,LancetInfDis,2015
![Page 63: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/63.jpg)
IV. An7bio7cuseinanimalsectorisincreasinggloballyinresponsetothetremendousgrowthindemandforanimalprotein
![Page 64: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/64.jpg)
Increase in demand for poultry in India and China between 2000 and 2030
FAO, 2011
![Page 65: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/65.jpg)
Antibiotic use for growth promotion and disease prevention
![Page 66: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/66.jpg)
2/3rds of the tonnage of antibiotics sold worldwide are used in agriculture
![Page 67: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/67.jpg)
• Totalconsump7oninChina-92700tonsin2013,
• 54000tonsofan7bio7csexcretedbyhumanandanimals-muchofthisenteredintothereceivingenvironmentfollowingvariouswastewatertreatmentsinto58riverbasinsofChina
Zhangetal,EnvSciTech,2015
![Page 68: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/68.jpg)
High-capacityquan7ta7vePCRarraysdetected149uniqueresistancegenesamongallofthefarmsamples,thetop63ARGsbeingenriched192-fold(median)upto28,000-fold(maximum)comparedwiththeirrespec7vean7bio7c-freemanureorsoilcontrols.
![Page 69: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/69.jpg)
Increase of antibiotic resistance genes among soils collected at five sites in The Netherlands from 1940 to 2008.
KnappetalEnvSciTech,2010
![Page 70: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/70.jpg)
![Page 71: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/71.jpg)
Temporalassocia7onbetweencontamina7onofretailchickenwithcediofur-resistantSalmonellaHeidelbergstrainsandincidenceofcediofurresistantSalmonellaHeidelberginfec7oninhumans
Du7letal,EID,2010
![Page 72: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/72.jpg)
Amounts, in mg, of veterinary antibacterial agents sold in 2007 per kg biomass of pig meat, poultry meat and cattle meat produced plus estimated live weight of dairy cattle. *2005 data. **The substances included vary from country to country.
Grave K et al. J. Antimicrob. Chemother. 2010;65:2037-2040
© The Author 2010. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 73: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/73.jpg)
Meat production and sales of antibiotic feed additives, United States, 1951-1970
Source:Cromwell(2002)
![Page 74: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/74.jpg)
![Page 75: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/75.jpg)
![Page 76: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/76.jpg)
Global antibiotic consumption in livestock (mg per 10 km2 pixels) 2010
Van Boeckel et al., PNAS, 2015
Log10 [(mg/pixel) + 1]
No data0 - 1 4 - 5 5 - 6 6 - 7 7 - 8 8 - 9 9 - 10 10 - 11
![Page 77: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/77.jpg)
Global antibiotic consumption in livestock (mg per 10 km2 pixels) 2010
Van Boeckel et al., PNAS, 2015
Log10 [(mg/pixel) + 1]
No data0 - 1 4 - 5 5 - 6 6 - 7 7 - 8 8 - 9 9 - 10 10 - 11
Globalconsump7onofan7microbialsinfoodanimalproduc7on• es7matedat63,151(±1,560)tonnesin2010• projectedtoriseby67%,to105,596(±3,605)tonnesby2030• hotspotslikeIndiawhereareasofhighconsump7on(30kgperkm2)for
industrialpoultryproduc7onareexpectedtogrow312%by2030
![Page 78: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/78.jpg)
Antibiotic consumption in livestock, top ten countries 2010–2030 (projected for 2030)
Van Boeckel et al., PNAS, 2015
![Page 79: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/79.jpg)
Sales of active ingredients of antibiotics for food-producing animals in Denmark
DANMAP 2013 (adapted)
![Page 80: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/80.jpg)
Laxminarayan et al, OECD Report, 2015
![Page 81: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/81.jpg)
Productivity reductions and costs per produced pig incurred by removing AGPs
Laxminarayan et al, OECD Report, 2015
![Page 82: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/82.jpg)
V. What’stheroleofinnova7on?
![Page 83: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/83.jpg)
![Page 84: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/84.jpg)
Loss of first line drugs increases drug costs
Source:WHOPolicyPerspec7ve2005,adaptedfromWHOModelFormulary,WHOClinicalGuidelinesandManagementSciencesforHealth’s2004Interna7onalDrugPriceIndicatorGuide(slidecourtesy:DavidHeymann)
![Page 85: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/85.jpg)
Laxminarayan,Science,2015
![Page 86: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/86.jpg)
Laxminarayan,Science,2015
![Page 87: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/87.jpg)
The rich pay with their wallets, the poor with their lives
Developed world cost per course of therapy D
eve
lop
ed
wo
rld
De
velo
pin
g w
orld
Supplier
Pfizer
GSK
Ortho-McNeill
Bayer
Roche
Pfizer
Roche
GSK
IDA
Eli Lilly
Oscient
various
Branded product only
Generic product available
Price/full course of therapy
Notes: *Chloramphenicol is not available in developed world—price is therefore estimated. †Ceftriaxone and ciprofloxacin may be available in some tertiary settings in developing world. Source: The Medical Letter (2006), Disease control priorities in developing countries, Lancet (2006), Expert interviews.
$1,500
$1,480
$666.80
$223.30
$16
$11
$5*
$3.60
$103
$39
$121
$145
$144.8
![Page 88: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/88.jpg)
Is the rate of new drug development declining?
![Page 89: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/89.jpg)
![Page 90: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/90.jpg)
Trends in development of new antibiotics
![Page 91: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/91.jpg)
Trends in development of new antibiotics
Ofthe61newan7bio7csapprovedbetween1980and2009,26(43%)werewithdrawneitherbecauseoftoxicityorlackofmarket,comparedwitha13%withdrawalrateforothertherapeu7ccategories(Ou^ersonetal2013)
![Page 92: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/92.jpg)
Systemic new molecular entity (NME) antibiotics still marketed in the US by period of introduction, 1980–2015*
Source: Outterson et al. 2013 *As of August 21, 2015; additional market discontinuations since 2009 are not calculated. Bedaquiline, approved for multidrug-resistant tuberculosis in 2012, is included.
![Page 93: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/93.jpg)
Laxminarayan, Science, 2014
![Page 94: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/94.jpg)
Laxminarayan, Science, 2014
Incen7vesfornewan7bio7cs,asproposedbyBARDAandEUmayencouragenewdrugdevelopmentbutdon’timpactincen7vesforusingdrugsappropriately
![Page 95: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/95.jpg)
ImageCourtesyofShu^erstock
• Diagnos7cs• VaccinesforStaphandGram-nega7veinfec7on
• Bacteriophages• Probio7cs• Quorumsensing
![Page 96: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/96.jpg)
![Page 97: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/97.jpg)
![Page 98: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/98.jpg)
![Page 99: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/99.jpg)
![Page 100: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/100.jpg)
![Page 101: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/101.jpg)
![Page 102: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/102.jpg)
ImageCourtesyofShu^erstock
![Page 103: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/103.jpg)
Resistancemap.org
![Page 104: Niaid apr 2016 rl](https://reader033.fdocuments.us/reader033/viewer/2022050811/5790772e1a28ab6874bc85f8/html5/thumbnails/104.jpg)
Slides are downloadable @ www.cddep.org
Thank you